Parvaneh Afsharian

Parvaneh Afsharian

Auto-generated profile, based on publicly available information

Parvaneh Afsharian

Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2015 in The Pharmacogenomics Journal
Verified
Journal Article
Open access
PDF file
IEIbrahim El-Serafi
Ibrahim El-Serafi
MFMohammad M. Fares
Mohammad M. Fares
MAManuchehr Abedi-Valugerdi
Manuchehr Abedi-Valugerdi
PAP Afsharian
P Afsharian
AMA Moshfegh
A Moshfegh
Moustapha HassanMoustapha Hassan
Moustapha Hassan
The role of cytochrome P450 2J2 (CYP2J2) in cyclophosphamide (Cy) bioactivation was investigated in patients, cells and microsomes. Gene expression analysis showed that CYP2J2 mRNA expression was significantly (P<0.01) higher in 20 patients with hematological malignancies compared with healthy controls. CYP2J2 expression showed significant upregulation (P<0.05) during Cy treatment before stem cell transplantation. Cy bioactivation was significantly correlated to CYP2J2 expression. Studies in HL-60 cells expressing CYP2J2 showed reduced cell viability when incubated with Cy (half maximal inhibitory concentration=3.6 mM). Inhibition of CYP2J2 using telmisartan reduced Cy bioactivation by 50% and improved cell survival. Cy incubated with recombinant CYP2J2 microsomes has resulted in apparent Km and Vmax values of 3.7–6.6 mM and 2.9–10.3 pmol/(min·pmol) CYP, respectively. This is the first study demonstrating that CYP2J2 is equally important to CYP2B6 in Cy metabolism. The heart, intestine and urinary bladder express high levels of CYP2J2; local Cy bioactivation may explain Cy-treatment-related toxicities in these organs.

12 September 2022 in Stem Cells International
Verified
Journal Article
Open access
PDF file
ZMZohre Miri-Lavasani
Zohre Miri-Lavasani
STShukoofeh Torabi
Shukoofeh Torabi
RSRoya Solhi
Roya Solhi
BSBahareh Shokouhian
Bahareh Shokouhian
PAParvaneh Afsharian
Parvaneh Afsharian
Massoud VosoughMassoud Vosough
Massoud Vosough
Background. A growing number of hepatocellular carcinoma (HCC), and recurrence frequency recently have drawn researchers’ attention to alternative approaches. The concept of differentiation therapies (DT) relies on inducing differentiation in HCC cells in order to inhibit recurrence and metastasis. Hepatocyte nuclear factor 4 alpha (HNF4α) is the key hepatogenesis transcription factor and its upregulation may decrease the invasiveness of cancerous cells by suppressing epithelial-mesenchymal transition (EMT). This study aimed to evaluate the effect of conjugated linoleic acid (CLA) treatment, natural ligand of HNF4α, on the proliferation, migration, and invasion capacities of HCC cells in vitro. Materials and Method. Sk-Hep-1 and Hep-3B cells were treated with different doses of CLA or BIM5078 [1-(2-chloro-5-nitrobenzenesulfonyl)−2-methylbenzimidazole], an HNF4α antagonist. The expression levels of HNF4a and EMT related genes were evaluated and associated to hepatocytic functionalities, migration, and colony formation capacities, as well as to viability and proliferation rate of HCC cells. Results. In both HCC lines, CLA treatment induced HNF4α expression in parallel to significantly decreased EMT marker levels, migration, colony formation capacity, and proliferation rate, whereas BIM5078 treatment resulted in the opposite effects. Moreover, CLA supplementation also upregulated ALB, ZO1, and HNF4α proteins as well as glycogen storage capacity in the treated HCC cells. Conclusion. CLA treatment can induce a remarkable hepatocytic differentiation in HCC cells and attenuates cancerous features. This could be as a result of HNF4a induction and EMT inhibition.

28 September 2020 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
ZHZohreh Hashemian
Zohreh Hashemian
PAParvaneh Afsharian
Parvaneh Afsharian
PFParvaneh Farzaneh
Parvaneh Farzaneh
PEPoopak Eftekhari-Yazdi
Poopak Eftekhari-Yazdi
FVFaezeh Vakhshiteh
Faezeh Vakhshiteh
ANAhmad Nasimian
Ahmad Nasimian

1 September 2023 in Armaghane Danesh
Verified
Journal Article
Open access
PDF file
EHE Hosseini
E Hosseini
MSMaryam Shahhoseini
Maryam Shahhoseini
PAP Afsharian
P Afsharian
FMF Mehrayin
F Mehrayin
MAM Ashrafi
M Ashrafi
RAR Aflatoonian
R Aflatoonian
Background & aim: Among the important factors affecting female infertility, endometriosis (with a prevalence rate of up to 50% in infertile women) has a special place. Endometriosis, which is known as the presence of endometrial glands and stroma outside the uterine tissue, causes a wide range of functional disorders in the process of ...